| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8438227 | EBioMedicine | 2017 | 6 Pages |
Abstract
Healthy middle-aged males that responded to an intravenous glucose injection with rapid glucose elimination during the first phase had an elevated risk of cancer during 40Â years of follow-up. First phase response to a glucose load might be related to cancer development.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
R.S. Falk, S. Tretli, J.E. Paulsen, L. Sandvik, J. Erikssen, T. Heir,